BSE Live
Oct 31, 16:01Prev. Close
896.20
Open Price
892.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Kwality Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 38.44 | 23.11 | 18.45 | 115.70 | 14.86 | |
| Diluted EPS (Rs.) | 38.44 | 23.11 | 18.45 | 115.70 | 14.86 | |
| Cash EPS (Rs.) | 56.04 | 41.92 | 33.14 | 125.95 | 21.06 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 255.43 | 216.98 | 193.93 | 175.17 | 59.47 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 256.21 | 217.75 | 194.70 | 175.94 | 60.24 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.30 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 356.78 | 296.03 | 241.89 | 439.59 | 252.02 | |
| PBDIT/Share (Rs.) | 79.38 | 65.98 | 60.94 | 168.88 | 29.73 | |
| PBIT/Share (Rs.) | 61.78 | 47.18 | 46.56 | 158.62 | 23.53 | |
| PBT/Share (Rs.) | 52.26 | 30.33 | 24.83 | 155.81 | 21.01 | |
| Net Profit/Share (Rs.) | 38.44 | 23.11 | 18.76 | 115.69 | 14.86 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 22.24 | 22.28 | 25.19 | 38.41 | 11.79 | |
| PBIT Margin (%) | 17.31 | 15.93 | 19.24 | 36.08 | 9.33 | |
| PBT Margin (%) | 14.64 | 10.24 | 10.26 | 35.44 | 8.33 | |
| Net Profit Margin (%) | 10.77 | 7.80 | 7.75 | 26.31 | 5.89 | |
| Return on Networth / Equity (%) | 15.05 | 10.65 | 9.67 | 66.04 | 24.97 | |
| Return on Capital Employed (%) | 22.79 | 19.92 | 20.94 | 77.25 | 26.93 | |
| Return on Assets (%) | 8.85 | 6.03 | 5.45 | 35.03 | 9.13 | |
| Total Debt/Equity (X) | 0.42 | 0.44 | 0.45 | 0.24 | 0.56 | |
| Asset Turnover Ratio (%) | 0.87 | 0.81 | 0.72 | 1.78 | 154.93 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.68 | 1.60 | 1.65 | 1.75 | 1.35 | |
| Quick Ratio (X) | 1.19 | 1.09 | 0.96 | 1.34 | 1.13 | |
| Inventory Turnover Ratio (X) | 4.57 | 1.87 | 1.62 | 5.64 | 15.06 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 999.90 | 517.88 | 403.29 | 634.24 | 87.69 | |
| EV/Net Operating Revenue (X) | 2.70 | 1.69 | 1.61 | 1.39 | 0.34 | |
| EV/EBITDA (X) | 12.14 | 7.56 | 6.38 | 3.62 | 2.84 | |
| MarketCap/Net Operating Revenue (X) | 2.44 | 1.38 | 1.27 | 1.32 | 0.22 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 3.40 | 1.89 | 1.59 | 3.31 | 0.94 | |
| Price/Net Operating Revenue | 2.44 | 1.38 | 1.27 | 1.32 | 0.22 | |
| Earnings Yield | 0.04 | 0.06 | 0.06 | 0.20 | 0.27 | 
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
20.05.2025
Kwality Pharmac Standalone March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
01.02.2025
Kwality Pharmac Consolidated December 2024 Net Sales at Rs 84.41 crore, up 8.08% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
20.05.2025
Kwality Pharmac Standalone March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
01.02.2025
Kwality Pharmac Consolidated December 2024 Net Sales at Rs 84.41 crore, up 8.08% Y-o-Y